BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 31513897)

  • 1. The D-alanyl-d-alanine carboxypeptidase enzyme is essential for virulence in the Schu S4 strain of Francisella tularensis and a dacD mutant is able to provide protection against a pneumonic challenge.
    Kijek TM; Mou S; Bachert BA; Kuehl KA; Williams JA; Daye SP; Worsham PL; Bozue JA
    Microb Pathog; 2019 Dec; 137():103742. PubMed ID: 31513897
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Spidlova P; Stojkova P; Dankova V; Senitkova I; Santic M; Pinkas D; Philimonenko V; Stulik J
    Front Cell Infect Microbiol; 2018; 8():111. PubMed ID: 29692981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.
    Twine S; Byström M; Chen W; Forsman M; Golovliov I; Johansson A; Kelly J; Lindgren H; Svensson K; Zingmark C; Conlan W; Sjöstedt A
    Infect Immun; 2005 Dec; 73(12):8345-52. PubMed ID: 16299332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Francisella tularensis SCHU S4 mutant deficient in γ-glutamyltransferase activity induces protective immunity: characterization of an attenuated vaccine candidate.
    Ireland PM; LeButt H; Thomas RM; Oyston PCF
    Microbiology (Reading); 2011 Nov; 157(Pt 11):3172-3179. PubMed ID: 21852349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an essential Francisella tularensis subsp. tularensis virulence factor.
    Qin A; Scott DW; Thompson JA; Mann BJ
    Infect Immun; 2009 Jan; 77(1):152-61. PubMed ID: 18981253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of TolC Orthologs to
    Kopping EJ; Doyle CR; Sampath V; Thanassi DG
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670554
    [No Abstract]   [Full Text] [Related]  

  • 8. Contribution of citrulline ureidase to Francisella tularensis strain Schu S4 pathogenesis.
    Mahawar M; Kirimanjeswara GS; Metzger DW; Bakshi CS
    J Bacteriol; 2009 Aug; 191(15):4798-806. PubMed ID: 19502406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge.
    Pechous RD; McCarthy TR; Mohapatra NP; Soni S; Penoske RM; Salzman NH; Frank DW; Gunn JS; Zahrt TC
    PLoS One; 2008 Jun; 3(6):e2487. PubMed ID: 18575611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Schu S4
    Cunningham AL; Mann BJ; Qin A; Santiago AE; Grassel C; Lipsky M; Vogel SN; Barry EM
    Virulence; 2020 Dec; 11(1):283-294. PubMed ID: 32241221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia.
    Golovliov I; Twine SM; Shen H; Sjostedt A; Conlan W
    PLoS One; 2013; 8(11):e78671. PubMed ID: 24236032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
    Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
    Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Francisella tularensis pilin homologs on pilus formation and virulence.
    Ark NM; Mann BJ
    Microb Pathog; 2011 Sep; 51(3):110-20. PubMed ID: 21605655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.
    Twine S; Shen H; Harris G; Chen W; Sjostedt A; Ryden P; Conlan W
    Vaccine; 2012 May; 30(24):3634-45. PubMed ID: 22484348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Francisella tularensis subsp. tularensis Schu S4 disulfide bond formation protein B, but not an RND-type efflux pump, is required for virulence.
    Qin A; Scott DW; Mann BJ
    Infect Immun; 2008 Jul; 76(7):3086-92. PubMed ID: 18458069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Francisella tularensis locus required for spermine responsiveness is necessary for virulence.
    Russo BC; Horzempa J; O'Dee DM; Schmitt DM; Brown MJ; Carlson PE; Xavier RJ; Nau GJ
    Infect Immun; 2011 Sep; 79(9):3665-76. PubMed ID: 21670171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
    Jia Q; Horwitz MA
    Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
    [No Abstract]   [Full Text] [Related]  

  • 18. Pullulanase Is Necessary for the Efficient Intracellular Growth of Francisella tularensis.
    Uda A; Sharma N; Takimoto K; Deyu T; Koyama Y; Park ES; Fujita O; Hotta A; Morikawa S
    PLoS One; 2016; 11(7):e0159740. PubMed ID: 27448164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Inner and Outer Membrane Proteins from
    Post DMB; Slütter B; Schilling B; Chande AT; Rasmussen JA; Jones BD; D'Souza AK; Reinders LM; Harty JT; Gibson BW; Apicella MA
    mBio; 2017 Oct; 8(5):. PubMed ID: 29018123
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.
    Conlan JW; Shen H; Golovliov I; Zingmark C; Oyston PC; Chen W; House RV; Sjöstedt A
    Vaccine; 2010 Feb; 28(7):1824-31. PubMed ID: 20018266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.